Rome, Italy

Emma Quaresima


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Rome, IT (1984 - 1986)
  • Casal Palocco, IT (1986)

Company Filing History:


Years Active: 1984-1986

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Emma Quaresima: Innovator in Pharmaceutical Chemistry

Introduction

Emma Quaresima is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel therapeutic agents. With a total of 5 patents to her name, her work has the potential to impact various medical treatments.

Latest Patents

Among her latest patents is the invention of mercapto acyl-carnitines and pharmaceutical compositions containing the same. This novel class of mercapto acyl-carnitines is characterized by a mercapto acyl radical derived from saturated mercapto acids with 2 to 10 carbon atoms. These compounds are synthesized through a process that involves nucleophilic substitution, replacing a halogen atom with a --SH group. The therapeutic applications of these mercapto acyl-carnitines include treatment for intoxications, burns, and as mucolytic agents.

Another significant patent involves alkoxy-acyl carnitines and their pharmaceutical compositions. This class of alkoxy-acyl carnitines features alkoxy-acyl radicals with 4 to 6 carbon atoms, such as methoxypropionyl and ethoxypropionyl. The preparation method includes reacting a carnitine salt solution with an alkoxy-acyl halogenide, leading to the formation of the corresponding salt. These alkoxy-acyl carnitines are therapeutically effective in treating cardiac disorders, hyperlipidaemias, and hyperlipoproteinaemias.

Career Highlights

Emma Quaresima is currently associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., where she continues to innovate in the pharmaceutical sector. Her research and inventions have positioned her as a key figure in the development of new therapeutic solutions.

Collaborations

Emma has collaborated with notable colleagues, including Maria Ornella Tinti and Carlo A Bagolini. These partnerships have further enhanced her research capabilities and contributed to her success in the field.

Conclusion

Emma Quaresima's contributions to pharmaceutical chemistry through her innovative patents demonstrate her commitment to advancing medical science. Her work not only showcases her expertise but also holds promise for improving patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…